General Healthy(605186)2021-04-19 16:00Financial Performance - Operating revenue increased by 33.97% to CNY 40,811,846.52 year-on-year[5] - Net profit attributable to shareholders rose by 8.34% to CNY 6,374,142.56[5] - Net profit after deducting non-recurring gains and losses surged by 47.64% to CNY 6,069,539.77[5] - Basic and diluted earnings per share decreased by 16.67% to CNY 0.05[7] - Total revenue for Q1 2021 was CNY 40,811,846.52, representing a 34.2% increase from CNY 30,462,390.90 in Q1 2020[27] - Net profit for Q1 2021 reached CNY 7,378,978.29, a 11.6% increase compared to CNY 6,614,680.73 in Q1 2020[28] - Operating profit for Q1 2021 was CNY 8,554,132.87, up 11.3% from CNY 7,687,190.27 in Q1 2020[28] - Comprehensive income for Q1 2021 totaled CNY 7,378,978.29, an increase from CNY 6,614,680.73 in Q1 2020[29] Cash Flow and Investments - Cash flow from operating activities showed a net outflow of CNY 51,838,262.91, worsening from a net outflow of CNY 44,991,571.69 in the previous year[5] - The company's cash flow from operating activities saw a 135.68% increase year-over-year, totaling ¥1,668,135.15, mainly due to higher interest income[17] - Cash inflow from operating activities in Q1 2021 was CNY 34,314,925.68, an increase of 25.5% compared to CNY 27,304,736.89 in Q1 2020[33] - Cash outflow from investing activities in Q1 2021 totaled CNY 64,800,526.88, significantly higher than CNY 17,178,468.19 in Q1 2020, indicating increased investment activity[34] - The company invested CNY 50,000,000.00 in Q1 2021, indicating a strategic focus on growth and expansion[37] Assets and Liabilities - Total assets decreased by 3.85% to CNY 958,984,906.41 compared to the end of the previous year[5] - Total assets amounted to CNY 997,404,072.75, with non-current assets totaling CNY 175,183,711.05[40] - Current liabilities decreased from ¥117,188,274.83 to ¥71,390,130.20, a reduction of about 39.1%[22] - Total liabilities reached CNY 119,788,274.83, with non-current liabilities at CNY 2,600,000.00[41] - The company reported a total current asset of ¥479,850,895.68, down from ¥512,239,855.07, a decrease of approximately 6.3%[25] Shareholder Information - The total number of shareholders reached 15,748 at the end of the reporting period[10] - The largest shareholder, Dai Jianwei, holds 42.00% of the shares[10] Research and Development - Research and development expenses surged by 51.18% year-over-year to ¥4,236,733.51, reflecting the company's increased investment in R&D projects[16] - R&D expenses increased to CNY 4,236,733.51 in Q1 2021, up 51.1% from CNY 2,802,363.50 in Q1 2020[27] Inventory and Costs - The cost of goods sold rose by 32.06% year-over-year to ¥19,154,037.80, in line with the revenue growth[15] - Inventory increased by 32.87% compared to the end of 2020, amounting to ¥32,718,943.17, driven by higher raw material purchases due to sales growth[13] - Total operating costs for Q1 2021 were CNY 31,247,677.80, up 30.2% from CNY 23,979,119.59 in Q1 2020[27] - Sales expenses rose by 34.07% year-over-year to ¥3,558,468.23, correlating with the increase in revenue[16] Other Financial Metrics - The weighted average return on equity decreased by 1.28 percentage points to 0.78%[5] - The company's tax payable decreased by 98.67% compared to the end of 2020, amounting to ¥374,080.21, due to the payment of fourth-quarter income tax[12] - The company's minority interest profit increased by 37.37% year-over-year, reaching ¥1,004,835.73, driven by higher profits from subsidiaries[18] - The company's cash and cash equivalents decreased to ¥438,938,640.02 from ¥559,879,717.59 at the end of 2020[21]